Therapeutic implications of drug interactions in the treatment of human immunodeficiency virus-related tuberculosis

被引:104
作者
Burman, WJ
Gallicano, K
Peloquin, C
机构
[1] Denver Publ Hlth, Denver Metro TB Clin, Denver, CO 80204 USA
[2] Univ Colorado, Hlth Sci Ctr, Dept Med, Div Infect Dis, Denver, CO 80262 USA
[3] Natl Jewish Med & Res Ctr, Infect Dis Pharmacokinet Lab, Denver, CO USA
[4] Ottawa Gen Hosp, Clin Invest Unit, Ottawa, ON K1H 8L6, Canada
关键词
D O I
10.1086/515174
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
[No abstract available]
引用
收藏
页码:419 / 429
页数:11
相关论文
共 108 条
[1]  
*ABB LAB, 1997, PROD INS
[2]   COMPARATIVE BIOAVAILABILITY OF ISONIAZID, RIFAMPIN, AND PYRAZINAMIDE ADMINISTERED IN FREE COMBINATION AND IN A FIXED TRIPLE FORMULATION DESIGNED FOR DAILY USE IN ANTITUBERCULOSIS CHEMOTHERAPY .2. 2-MONTH, DAILY ADMINISTRATION STUDY [J].
ACOCELLA, G ;
NONIS, A ;
PERNA, G ;
PATANE, E ;
GIALDRONIGRASSI, G ;
GRASSI, C .
AMERICAN REVIEW OF RESPIRATORY DISEASE, 1988, 138 (04) :886-890
[3]   CLINICAL PHARMACOKINETICS OF RIFAMPICIN [J].
ACOCELLA, G .
CLINICAL PHARMACOKINETICS, 1978, 3 (02) :108-127
[4]  
AMEER B, 1982, Clinical Pharmacy, V1, P156
[5]   Abnormal expression of a 170-kilodalton P-glycoprotein encoded by MDR1 gene, a metabolically active efflux pump, in CD4(+) and CD8(+) T cells from patients with human immunodeficiency virus type 1 infection [J].
Andreana, A ;
Aggarwal, S ;
Gollapudi, S ;
Wien, D ;
Tsuruo, T ;
Gupta, S .
AIDS RESEARCH AND HUMAN RETROVIRUSES, 1996, 12 (15) :1457-1462
[6]   The effect of zidovudine dose on the formation of intracellular phosphorylated metabolites [J].
Barry, MG ;
Khoo, SH ;
Veal, GJ ;
Hoggard, PG ;
Gibbons, SE ;
Wilkins, EGL ;
Williams, O ;
Breckenridge, AM ;
Back, DJ .
AIDS, 1996, 10 (12) :1361-1367
[7]  
BENEDEK IH, 1998, 12 WORLD AIDS C, P829
[8]  
Benedek IH, 1998, CLIN INFECT DIS, V27, P1008
[9]  
Benson Constance A., 1997, American Journal of Medicine, V102, P32
[10]  
BERNING SE, 1992, NEW ENGL J MED, V327, P1817, DOI 10.1056/NEJM199212173272514